Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

Pages: 1034 Published: March 29, 2022 Report Code: GDHC6864CTIDB

The cervical cancer clinical trial analysis report provides top-line data relating to the clinical trials on cervical cancer. It includes an overview of the trials count and their average enrolment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. Moreover, the report provides prominent drug names and trial counts for in-progress trials.

What is the regional outlook of the cervical cancer clinical trials market?

The cervical cancer clinical trials market is the largest in the Asia Pacific region followed by North America, Europe, South and Central America, and the Middle East and Africa. In terms of country, as of March 2022, the US has the highest number of cervical cancer clinical trials, followed by China, Japan, France, Spain, the UK, Canada, South Korea, Germany, and Italy. China has the highest average patient enrollment in cervical cancer clinical trials. 

G7 countries:

Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of cervical cancer to oncology clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.

E7 countries:

Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of cervical cancer to oncology clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority was in China.

Cervical cancer clinical trials market, by region

Cervical cancer clinical trials market, by region

For more regional insights, download a free report sample

What are the key sponsor types in the cervical cancer clinical trials market?

The key sponsor types in the cervical cancer clinical trials market are institution, company, and government. Out of them, institution dominates the market.

Cervical cancer clinical trials market, by sponsor types

Cervical cancer clinical trials market, by sponsor types

For more sponsor type insights, download a free report sample

Which are the key companies in the cervical cancer clinical trials market?

The key companies in the cervical cancer clinical trials market are Merck & Co Inc, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Pfizer Inc, Jiangsu Hengrui Medicine Co Ltd, Yangshengtang Co Ltd, Xiamen Innovax Biotech Co Ltd, and Sanofi.

Cervical cancer clinical trials market, by key companies

Cervical cancer clinical trials market, by key companies

To know more about key companies, download a free report sample

Market report scope

Key regions Asia-Pacific, Northern America, Europe, Middle East and Africa, and South and Central America
Key sponsor types Institution, Company, and Government
Key companies Merck & Co Inc, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Pfizer Inc, Jiangsu Hengrui Medicine Co Ltd, Yangshengtang Co Ltd, Xiamen Innovax Biotech Co Ltd, and Sanofi

 The report provides:

  • A snapshot of the global clinical trials landscape.
  • Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status.
  • Reviews of top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
  • All the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for unaccomplishment.
  • Enrollment trends for the past five years.
  • Latest news for the past three months.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment.
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
  • Provides top level analysis of global clinical trials market which helps in identifying key business opportunities.
  • Supports understanding of trials count and enrollment trends by country in the global therapeutics market.
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
  • Facilitates clinical trial assessment of the indication on a global, regional and country level.

Key Players

Merck & Co Inc
GlaxoSmithKline Plc
AstraZeneca Plc
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Co
Pfizer Inc
Jiangsu Hengrui Medicine Co Ltd
Sanofi
Xiamen Innovax Biotech Co Ltd
Yangshengtang Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Disclaimer

Source

List of Tables

List of Tables

Cervical Cancer Therapeutics, Global, Clinical Trials by Region, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2022*

Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2022*

Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2022*

Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials by Phase, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

Cervical Cancer Therapeutics, Global, Clinical Trials by Region (%), 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*

Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*

Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2022*

Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*

Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2022*

Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2022*

Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2022*

Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*

Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

GlobalData Methodology

Frequently Asked Questions

The key regions in the cervical cancer clinical trials market are Asia-Pacific, North America, Europe, Middle East and Africa, and South and Central America.

The key sponsor types in the cervical cancer clinical trials market are institution, company, and government.

The key companies in the cervical cancer clinical trials market are Merck & Co Inc, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Pfizer Inc, Jiangsu Hengrui Medicine Co Ltd, Yangshengtang Co Ltd, Xiamen Innovax Biotech Co Ltd, and Sanofi.

$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.